Increasing proliferation of murine adipose tissue-derived mesenchymal stem cells by TNF-α plus IFN-γ

Immunopharmacology and Immunotoxicology

Volumn 38, Issue 2, 2016, Pages 68-76

  Mohammadpour, Hemn ^a   Pourfathollah, Ali Akbar ^a   Zarif, Mahin Nikougoftar ^b   Hashemi, Sayed Mahmoud ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IFN ; mesenchymal stem cells; pluripotency; proliferation; TNF

Indexed keywords

GAMMA INTERFERON; HLA G ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; SOMATOMEDIN C; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR NECROSIS FACTOR ALPHA; IFNG PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMING UNIT; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH RATE; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADIPOSE TISSUE; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84948775122     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2015.1115519     Document Type: Article

References (41)

1. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-650.
2. Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974;17:331-340.
3. Hoke NN, Salloum FN, Kass DA, et al. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Stem Cells 2012;30:326-335.
4. Trivanović D, Mojsilović S, Ilić V, et al. Immunomodulatory capacity of human mesenchymal stem cells isolated from adipose tissue, dental pulp, peripheral blood and umbilical cord Wharton's jelly. Centr Eur J Immunol 2013;38:421-429.
5. Ben-Ami E, Berrih-Aknin S, Miller A. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev 2011;10:410-415.
6. Lee RH, Yoon N, Reneau JC, Prockop DJ. Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity. Cell Stem Cell 2012;11:825-835.
7. Li W, Ren G, Huang Y, et al. Mesenchymal stem cells: a doubleedged sword in regulating immune responses. Cell Death Differ 2012;19:1505-1513.
8. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-926.
9. Kim YI, Ryu J-S, Yeo JE, et al. Overexpression of TGF-β1 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cells. Biochem Biophys Res Commun 2014;450:1593-1599.
10. Burnouf T, Kuo YP, Huang CT, et al. A virally inactivated plateletderived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets. Transfusion 2010;50: 1702-1711.
11. Fekete N, Gadelorge M, Fürst D, et al. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 2012;14: 540-554.
12. Liu M, Liu N, Zang R, et al. Engineering stem cell niches in bioreactors. World J Stem Cells 2013;5:124-135.
13. Sun L-Y, Pang C-Y, Li D-K, et al. Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation. J Biomed Sci 2013;20:53.
14. Han S-M, Han S-H, Coh Y-R, et al. Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med 2014;46:e101.
15. Cuerquis J, Romieu-Mourez R, François M, et al. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-g and tumor necrosis factor-α stimulation. Cytotherapy 2014;16:191-202.
16. Wang L, Zhao Y, Liu Y, et al. IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkB signaling. Stem Cells 2013;31:1383-1395.
17. Liu X, Liu D, Zang C, et al. [IFN-γ stimulation enhances immunosuppressive capability of human umbilical cord mesenchymal stem cells]. Shi Yan Xue Ye Xue Za Zhi 2014;22: 605-611.
18. Prasanna JS, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 2010;5: e9016.
19. Du J, Zhou L, Chen X, et al. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. Int J Biochem Cell Biol 2012;44:1305-1314.
20. Koning JJ, Kooij G, De Vries HE, et al. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol 2013;4:49.
21. Choudhery MS, Khan M, Mahmood R, et al. Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium. J Cell Mol Med 2012;16: 2518-2529.
22. Pochampally R. Colony forming unit assays for MSCs. Methods Mol Biol 2008;449:83-91.
23. Ghali O, Chauveau C, Hardouin P, et al. TNF-alpha's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J Bone Miner Res 2010;25: 1616-1626.
24. Croitoru-Lamoury J, Lamoury FM, Caristo M, et al. Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS One 2011;6:e14698.
25. Anderson P, Carrillo-Gálvez AB, García-Pérez A, et al. CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS One 2013;8: e76979.
26. Yamamoto M, Nakata H, Hao J, et al. Osteogenic potential of mouse adipose-derived stem cells sorted for CD90 and CD105 in vitro. Stem Cells Int 2014;2014:576358.
27. Rosu-Myles M, Fair J, Pearce N, Mehic J. Non-multipotent stroma inhibit the proliferation and differentiation of mesenchymal stromal cells in vitro. Cytotherapy 2010;12:818-830.
28. Lv X-J, Zhou G-D, Liu Y, et al. In vitro proliferation and differentiation of adipose-derived stem cells isolated using anti-CD105 magnetic beads. Int J Mol Med 2012;30:826-834.
29. Adachi K, Suemori H, Yasuda S, et al. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 2010;15:455-470.
30. Wang Z, Oron E, Nelson B, et al. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012;10:440-454.
31. Niwa H, Miyazaki JI, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
32. Yoon D, Kim Y, Jung H, et al. Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Proliferat 2011;44:428-440.
33. Liu TM, Wu YN, Guo XM, et al. Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev 2009; 18:1013-1022.
34. Steinert AF, Ghivizzani SC, Rethwilm A, et al. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 2007;9:213.
35. Oerlecke I, Bauer E, Dittmer A, et al. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression. PLoS One 2013;8:e54261.
36. Jian H, Shen X, Liu I, et al. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 2006;20:666-674.
37. Huat TJ, Khan AA, Pati S, et al. IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells. BMC Neurosci 2014;15:91.
38. Huang H, Zhao N, Xu X, et al. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Proliferat 2011;44:420-427.
39. Mohammadpour H, Pourfathollah AA, Zarif MN, Tahoori MT. TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells. Int Immunopharmacol 2015;28: 1009-1017.
40. Montespan F, Deschaseaux F, Sensébé L, et al. Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy. J Immunol Res 2014;2014:230346.
41. Wen L, Zhu M, Madigan MC, et al. Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells. PLoS One 2014;9:e101841.